ANO1 and malignant colon neoplasm: Due to highly expression of DOG1 in CTCs derived from colon cancer patients, we propose a hypothesis that our novel anti-DOG1-DM4-ADC may efficiently directly target these DOG1 positive CTCs, therefor, prevent tumor recurrence or metastasis.